InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
1.70%
)
US TECH 100
19,317.60
(
2.44%
)
Dow Jones
42,025.19
(
1.26%
)
Brent Oil
74.25
(
2.58%
)
Bitcoin
62,949.66
(
2.07%
)
Post# of 253159
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

marthambles

Send PM Follow Ignore
Followers 8
Posts 1326
Boards Moderated 0
Alias Born 04/26/2004

marthambles

Re: jbog post# 211000

Friday, 12/08/2017 3:06:41 PM

Friday, December 08, 2017 3:06:41 PM

Post# of 253159
RVNC - regarding the PF trial, botox is already used in this indication (although sparingly, apparently). The primary and secondary endpoints relate to efficacy, but not to duration. Do we anticipate anything coming out of this trial comparing efficacy to Botox (which has been the subject of at least one placebo controlled trial in this indication see https://www.ncbi.nlm.nih.gov/pubmed/27630253)?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up